TELA Bio to Announce First Quarter 2021 Financial Results
April 29 2021 - 4:00PM
TELA Bio, Inc. ("TELA"), a commercial-stage medical technology
company focused on designing, developing, and marketing innovative
tissue reinforcement materials to address unmet needs in soft
tissue reconstruction, today announced that the company will report
first quarter ended March 31, 2021, financial results on Thursday,
May 13, 2021. TELA Bio’s management will host a conference call and
webcast at 4:30 p.m. ET that day to discuss the financial results
and provide a corporate update.
Conference Call and Webcast DetailsThe
conference call can be accessed by dialing 855-548-1219 for
participants in the U.S. or Canada and 409-217-8881 for
international callers, using conference ID 7381947. A live and
archived webcast of the event can be accessed via the Events &
Presentations page of the investor section of TELA's website.
About TELA Bio, Inc.TELA Bio Inc. (NASDAQ:
TELA) is a commercial-stage medical technology company focused on
designing, developing, and marketing innovative tissue
reinforcement materials to address unmet needs in soft tissue
reconstruction. The company is committed to providing advanced,
economically effective biologic material repair solutions to
patients to minimize long-term exposure to permanent synthetic
materials and improve clinical outcomes. TELA Bio’s OviTex® and
OviTex PRS Reinforced Tissue Matrix products are purposefully
designed to address the shortcomings of existing reinforcement
materials in hernia repair, abdominal wall reconstruction and
plastic and reconstructive surgery. For more information, visit
www.telabio.com.
Investor ContactGreg
Chodaczek347-620-7010 ir@telabio.com
TELA Bio (NASDAQ:TELA)
Historical Stock Chart
From Mar 2024 to Apr 2024
TELA Bio (NASDAQ:TELA)
Historical Stock Chart
From Apr 2023 to Apr 2024